SCHEMBL2498032

SCHEMBL2498032

O=P(Oc1ccccc1)(Oc1ccccc1)c1c(-c2ccc(-c3cccs3)s2)sc(-c2ccc(-c3cccs3)s2)c1P(=O)(Oc1ccccc1)Oc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 4/20 0.41
L3MBTL1 Q9Y468 3/20 0.40
TDP1 Q9NUW8 1/20 0.40
HDAC1 Q13547 1/20 0.39
ALDH1A1 P00352 5/20 0.37
KDM4E B2RXH2 3/20 0.37
LMNA P02545 3/20 0.37
MAPT P10636 3/20 0.37
GAA P10253 2/20 0.37
GLA P06280 1/20 0.37
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
TP53 P04637 2/20 0.36
POLB P06746 2/20 0.36
MAPK1 P28482 2/20 0.36
CASP1 P29466 2/20 0.36
CASP7 P55210 2/20 0.36
HSD17B10 Q99714 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2491536 0.78 DPP4 (0.41) DPP4L3MBTL1HDAC1ALDH1A1KDM4E
SCHEMBL2491472 0.78 DPP4 (0.49) DPP4L3MBTL1HDAC1ALDH1A1KDM4E
SCHEMBL2497371 0.78 DPP4 (0.49) DPP4L3MBTL1HDAC1ALDH1A1KDM4E
SCHEMBL12191771 0.77 DPP4 (0.48) DPP4L3MBTL1HDAC1ALDH1A1KDM4E
SCHEMBL2496787 0.77 DPP4 (0.48) DPP4L3MBTL1HDAC1ALDH1A1KDM4E
SCHEMBL2494288 0.76 HDAC1 (0.49) DPP4L3MBTL1HDAC1ALDH1A1KDM4E
SCHEMBL12191767 0.74 DPP4 (0.42) DPP4L3MBTL1HDAC1ALDH1A1KDM4E
SCHEMBL2498947 0.73 DPP4 (0.43) DPP4L3MBTL1HDAC1ALDH1A1KDM4E
SCHEMBL2493159 0.72 DPP4 (0.40) DPP4L3MBTL1HDAC1ALDH1A1KDM4E
SCHEMBL2498942 0.72 DPP4 (0.40) DPP4L3MBTL1HDAC1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1882694-B1 OLIGOMERS AND POLYMERS OF THIOPHENE COMPOUNDS HAVING PHOSPHORIC ESTER AND PROCESS FOR PRODUCING THE SAME NISSAN CHEMICAL IND LTD (JP) 2013-04-03 EP disclosed
US-8030438-B2 Thiophene compound having phosphoric ester and process for producing the same NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-10-04 US disclosed
US-8030438-B2 Thiophene compound having phosphoric ester and process for producing the same NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-10-04 US disclosed
US-20100019229-A1 Thiophene compound having phosphoric ester and process for producing the same NISSAN CHEMICAL INDUSTRIES, LTD (JP) 2010-01-28 US disclosed
US-20100019229-A1 Thiophene compound having phosphoric ester and process for producing the same NISSAN CHEMICAL INDUSTRIES, LTD (JP) 2010-01-28 US disclosed
EP-1882694-A1 THIOPHENE COMPOUND HAVING PHOSPHORIC ESTER AND PROCESS FOR PRODUCING THE SAME Nissan Chemical Industries, Ltd. (JP) 2008-01-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100019229-A1 Thiophene compound having phosphoric ester and process for producing the same RRP12, NR2E1, TST DPP4 3787/4885L3MBTL1 2391/4885TDP1 2467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.